RxDoctor Payments Data

Nathan Morgan, PA

Physician Assistant · Las Vegas, NVNPI 1215364674

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Arcutis Biotherapeutics, Inc. at 24.5% of the total. Among physician assistant clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$43,881in general payments, 2019–2025

Across 932 payments — averaging $47.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arcutis Biotherapeutics, Inc.$11K
  • UCB, Inc.$6K
  • AbbVie$5K
  • Johnson & Johnson$4K
  • Dermavant Sciences, Inc.$3K
  • LEO Pharma Inc.$3K
  • plus $12K from 25 others

What the payments were for

  • Consulting fees$19,33044%
  • Speaking & faculty fees$7202%
  • Travel & lodging$3,7389%
  • Food & beverage$18,98043%
  • Education$1,1133%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,881 in reported general payments places this provider in the 95th percentile of 881 physician assistant providers in Nevada.

See all physician assistant providers in Nevada

Medicare billing

Part B allowed, 2024
$279,547
Medicare patients
970
Services billed
8,153

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab15$227,938
Dupixent PenDupilumab42$150,586
Humira(Cf) PenAdalimumab15$120,640
Taltz AutoinjectorIxekizumab16$109,675
Tacrolimus45$8,202
Clobetasol Propionate94$4,614
Betamethasone Dipropionate107$4,104
Halobetasol Propionate44$2,268
Metronidazole34$2,240
Fluorouracil27$2,190
Fluocinonide46$1,811
Mometasone Furoate109$1,695
Ketoconazole115$1,683
Clindamycin Phosphate19$1,654
Triamcinolone Acetonide122$1,635

Paid to pharmacies, not to this prescriber.

Other physician assistant in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →